Andrew is a Chemistry PhD candidate in the Shalek Lab. He is interested developing novel RNA-seq technologies and studying resistance mechanisms in cancer. He captains the lab volleyball team, Seq-and-Destroy, and plays ice hockey in his free time.

As a chemistry major at Emory University, Andrew worked in Professor Dennis Liotta’s lab synthesizing nucleotide reverse transcriptase inhibitors.

Optofluidic real-time cell sorter for longitudinal CTC studies in mouse models of cancer
  • Hamza B. et al.,
  • PNAS,
  • 2019
  • Technology
  • Cancer
  • Biology
  • Computational Methods
  • R&D
  • Jay Prakadan
  • Andrew Navia
  • Peter Winter
  • Riley Drake
  • Alejandro Gupta
  • Alex K. Shalek
Initiation of Antiviral B Cell Immunity Relies on Innate Signals from Spatially Positioned NKT Cells
  • Gaya M. et al.,
  • Cell,
  • 2017
  • Immunology
  • Genomics
  • Andrew Navia
  • Alex K. Shalek